Revenues: | |
Genetic analysis product sales and services | 2.78M |
Diagnostic services | 26.51M |
Total revenues | 29.29M |
Cost of revenues: | |
Cost of genetic analysis product sales and services | |
Cost of diagnostic services | 13.75M |
Total cost of revenues | |
Gross margin | |
Operating expenses: | |
Research and development | 4.07M |
Selling and marketing | 8.42M |
General and administrative | 7.31M |
Litigation settlement, net of revaluation gains | |
Total operating expenses | 33.74M |
Loss from operations | -4.46M |
Other income (loss), net | 158K |
Loss before income taxes | -6.25M |
Income tax (expense) benefit | -57K |
Net loss | -6.31M |
Net loss per common share, basic and diluted | |
Weighted average shares outstanding, basic and diluted |